Literature DB >> 1582424

Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factor.

J B Moore1, G L Smith.   

Abstract

Vaccinia virus open reading frame (ORF) SalF7L has 31% amino acid identity to human 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase (3 beta-HSD). Here we show that SalF7L encodes an active 3 beta-HSD, by the conversion of pregnenolone to the steroid hormone progesterone. The gene is transcribed early during infection into a 1.4 kb mRNA from an initiation site 12 bp upstream of the ORF. An antiserum raised against bacterially expressed SalF7L immunoprecipitated a 38 kDa polypeptide from infected cells, but not from mock infected cells or from cells infected with a mutant virus from which the SalF7L ORF had been removed. Deletion of the gene had no effect on virus replication in CV-1 cells in culture, yet the deletion mutant was attenuated when intranasally inoculated into mice. This steroid hormone synthesizing enzyme is a novel type of virus virulence factor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1582424      PMCID: PMC556657          DOI: 10.1002/j.1460-2075.1992.tb05251.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  55 in total

Review 1.  DNA binding specificity of steroid receptors.

Authors:  J M Berg
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

2.  Micromethod for the determination of 3-beta-HSD activity in cultured cells.

Authors:  H C Bauer; H Bauer
Journal:  J Steroid Biochem       Date:  1989-10       Impact factor: 4.292

3.  Conserved TAAATG sequence at the transcriptional and translational initiation sites of vaccinia virus late genes deduced by structural and functional analysis of the HindIII H genome fragment.

Authors:  J L Rosel; P L Earl; J P Weir; B Moss
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

4.  Structure of vaccinia virus late promoters.

Authors:  A J Davison; B Moss
Journal:  J Mol Biol       Date:  1989-12-20       Impact factor: 5.469

5.  Full length cDNA structure and deduced amino acid sequence of human 3 beta-hydroxy-5-ene steroid dehydrogenase.

Authors:  V Luu The; Y Lachance; C Labrie; G Leblanc; J L Thomas; R C Strickler; F Labrie
Journal:  Mol Endocrinol       Date:  1989-08

6.  Non-essential genes in the vaccinia virus HindIII K fragment: a gene related to serine protease inhibitors and a gene related to the 37K vaccinia virus major envelope antigen.

Authors:  M E Boursnell; I J Foulds; J I Campbell; M M Binns
Journal:  J Gen Virol       Date:  1988-12       Impact factor: 3.891

7.  Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4.

Authors:  R A Daynes; B A Araneo
Journal:  Eur J Immunol       Date:  1989-12       Impact factor: 5.532

8.  Oligonucleotide sequence signaling transcriptional termination of vaccinia virus early genes.

Authors:  L Yuen; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

9.  Role of prostaglandins and non-steroid anti-inflammatory drugs in the pathogenicity of vaccinia virus.

Authors:  G Zavagno; B Jaffe; M Esteban
Journal:  J Gen Virol       Date:  1987-02       Impact factor: 3.891

10.  Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13,800-Da secreted protein.

Authors:  G J Kotwal; A W Hügin; B Moss
Journal:  Virology       Date:  1989-08       Impact factor: 3.616

View more
  28 in total

1.  Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence.

Authors:  W H Zhang; D Wilcock; G L Smith
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Identification of second-site mutations that enhance release and spread of vaccinia virus.

Authors:  Ehud Katz; Elizabeth Wolffe; Bernard Moss
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Mutations in the vaccinia virus A33R and B5R envelope proteins that enhance release of extracellular virions and eliminate formation of actin-containing microvilli without preventing tyrosine phosphorylation of the A36R protein.

Authors:  Ehud Katz; Brian M Ward; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

4.  Xenopus-FV3 host-pathogen interactions and immune evasion.

Authors:  Robert Jacques; Eva-Stina Edholm; Sanchez Jazz; Torres-Luquis Odalys; De Jesús Andino Francisco
Journal:  Virology       Date:  2017-06-16       Impact factor: 3.616

Review 5.  Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety.

Authors:  B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

6.  Interaction cloning of NS1-I, a human protein that binds to the nonstructural NS1 proteins of influenza A and B viruses.

Authors:  T Wolff; R E O'Neill; P Palese
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

7.  The genome of fowlpox virus.

Authors:  C L Afonso; E R Tulman; Z Lu; L Zsak; G F Kutish; D L Rock
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

8.  Dose-dependent lymphocyte apoptosis following respiratory infection with Vaccinia virus.

Authors:  Nicole L Yates; Rama D Yammani; Martha A Alexander-Miller
Journal:  Virus Res       Date:  2008-08-23       Impact factor: 3.303

9.  Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens.

Authors:  Lucas Sánchez-Sampedro; Carmen Elena Gómez; Ernesto Mejías-Pérez; Eva Pérez-Jiménez; Juan Carlos Oliveros; Mariano Esteban
Journal:  J Virol       Date:  2013-04-17       Impact factor: 5.103

Review 10.  Monkeypox virus and insights into its immunomodulatory proteins.

Authors:  Jessica R Weaver; Stuart N Isaacs
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.